XML 22 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Statement of Cash Flows
 7 Months Ended
Dec. 31, 2024
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (135,571)
Adjustments to reconcile net loss to net cash used in operating activities:  
Formation cost paid by Sponsor in exchange for issuance of founder shares 16,241
Payment of operation costs through promissory note 15,420
Change in fair value of warrant liabilities 415,000
Transaction costs 116,039
Change in fair value – over-allotment liability (12,792)
Dividends earned on investments held in Trust Account (749,825)
Changes in operating assets and liabilities:  
Prepaid expenses (1,637)
Accounts Payable 204,305
Net cash used in operating activities (132,820)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (166,415,000)
Net cash used in investing activities (166,415,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units, net of underwriting discounts paid 162,680,000
Proceeds from sale of Private Placement Warrants 5,985,000
Repayment of promissory note - related party (105,274)
Payments of offering costs (468,340)
Net cash provided by financing activities 168,091,386
Net Change in Cash 1,543,566
Cash - Beginning of period
Cash - End of year 1,543,566
Non-Cash Investing and Financing Activities:  
Issuance of founder shares 25,000
Offering costs included in accrued offering costs 78,303
Offering costs paid by promissory note 89,854
Offering costs paid via prepaid expense 8,759
Offering costs charged to additional paid in capital 638,427
Over-allotment liability at IPO date 77,163
Deferred underwriting fee payable 6,567,193
Initial classification of warrant liability - public $ 1,743,000